[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100650197":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":12,"centralContacts":17,"locations":22,"responsibleParty":39,"collaborators":7,"id":41,"slug":42,"hasResults":43,"nctId":44,"briefTitle":45,"officialTitle":45,"acronym":7,"eligibilityCriteria":46,"healthyVolunteers":43,"sex":47,"minAge":7,"maxAge":7,"enrollmentInfo":48,"targetDuration":7,"studyType":51,"phases":7,"briefSummary":52,"conditions":53,"keywords":7,"overallStatus":59,"whyStopped":7,"lastUpdateSubmitDate":60,"lastUpdatePostDateStruct":61,"startDateStruct":64,"completionDateStruct":66,"leadSponsor":68,"locationsCount":69},{"fullName":5,"class":6},"M.D. Anderson Cancer Center","OTHER",null,[9],{"type":6,"name":10,"description":11,"armGroupLabels":7,"otherNames":7},"data collection","The study will collect clinical, imaging, laboratory, treatment, and outcome data from the electronic medical record, radiation treatment planning systems, imaging archives, and other institutional clinical databases",[13],{"name":14,"affiliation":15,"role":16},"Omran Saifi, MD","UT MD Anderson Cancer Center","PRINCIPAL_INVESTIGATOR",[18],{"name":14,"role":19,"phone":20,"phoneExt":7,"email":21},"CONTACT","832-829-0337","OSaifi@mdanderson.org",[23],{"facility":15,"status":7,"city":24,"state":25,"zip":26,"country":27,"countryCode":28,"cosmosGeoPoint":29,"geoPoint":34,"contacts":35},"Houston","Texas","77030","United States","US",{"type":30,"coordinates":31},"Point",[32,33],-95.36327,29.76328,{"lat":33,"lon":32},[36,37],{"name":14,"role":19,"phone":20,"phoneExt":7,"email":21},{"name":14,"role":38,"phone":7,"phoneExt":7,"email":7},"SUB_INVESTIGATOR",{"type":40,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100650197","quantitative-marrow-imaging-marrow-reserve-and-clinical-outcomes-in-patients-undergoing-radiotherapy-for-hematologic-and-related-disorders-100650197",false,"NCT07743476","Quantitative Marrow Imaging, Marrow Reserve, And Clinical Outcomes In Patients Undergoing Radiotherapy For Hematologic And Related Disorders","Inclusion Criteria\n\n* Undergoing or previously underwent radiotherapy at The University of Texas MD Anderson Cancer Center for hematologic or related disorders.\n* Available clinical, imaging, laboratory, treatment, and\u002For outcome data relevant to study objectives.\n* Ability to provide informed consent for prospective participation, when applicable.\n\nExclusion Criteria\n\nParticipants meeting any of the following criteria will be excluded:\n\n* Inability to provide informed consent, or when applicable, the absence of a legally authorized representative able to provide consent for prospective participation.\n* Insufficient clinical information available to support study objectives.\n* Pregnant women","ALL",{"count":49,"type":50},1000,"ESTIMATED","OBSERVATIONAL","To create a registry for people who are undergoing or previously underwent radiotherapy for hematologic or related disorders.",[54,55,56,57,58],"Quantitative Marrow Imaging","Marrow Reserve","Clinical Outcomes","Radiotherapy","Hematologic","NOT_YET_RECRUITING","2026-07-30",{"date":62,"type":63},"2026-08-04","ACTUAL",{"date":65,"type":50},"2027-01-23",{"date":67,"type":50},"2038-12-31",{"name":5,"class":6},1]